Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI

Chen-En Ma, Sunita Ghosh, Catherine Leyshon, Nikki Blosser, Deonne Dersch‐Mills, Jennifer Jupp, Lynn Savoie, Elena Liew, Kareem Jamani